Search research articles
Contact Us
Filters
Showing results (181-190 of 234) with videos related to
Page
of 24
Sort By:
The American Journal of Medicine
|
December 29, 2010
Race, Bleeding, and Outcomes in STEMI Patients Treated with Fibrinolytic Therapy
Rajendra H Mehta, Amanda Stebbins, Renato D Lopes, et al.
Vascular Medicine (London, England)
|
April 25, 2007
ACCF/SCAI/SVMB/SIR/ASITN 2007 Clinical Expert Consensus Document on carotid stenting
Eric R Bates, Joseph D Babb, Donald E Casey, et al.
Lancet (London, England)
|
September 4, 2009
Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials
Michelle L O'Donoghue, Eugene Braunwald, Elliott M Antman, et al.
JACC. Case Reports
|
February 13, 2023
2022 Year in Review: Countdown of the Best Manuscripts in 2022
Julia Grapsa, Mary Norine Walsh, Maurice Lionel Enriquez-Sarano, et al.
Journal of the American College of Cardiology
|
January 9, 2007
ACCF/SCAI/SVMB/SIR/ASITN 2007 clinical expert consensus document on carotid stenting: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting)
, , , et al.
Circulation
|
November 1, 2006
Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy
Duane S Pinto, Ajay J Kirtane, Brahmajee K Nallamothu, et al.
The American Journal of Cardiology
|
October 6, 2009
Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial
David J Maron, John A Spertus, G B John Mancini, et al.
Circulation. Cardiovascular Interventions
|
November 3, 2011
Angiographic disease progression and residual risk of cardiovascular events while on optimal medical therapy: observations from the COURAGE Trial
G B John Mancini, Pamela M Hartigan, Eric R Bates, et al.
American Heart Journal
|
September 11, 2013
Prognostic importance of coronary anatomy and left ventricular ejection fraction despite optimal therapy: assessment of residual risk in the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation Trial
G B John Mancini, Pamela M Hartigan, Eric R Bates, et al.
The Canadian Journal of Cardiology
|
August 28, 2004
ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction)
Elliott M Antman, Daniel T Anbe, Paul Wayne Armstrong, et al.
Page
of 24
Search research articles
Search
Showing results (181-190 of 234) with videos related to
Sort By:
Page
of 24
The American Journal of Medicine
|
December 29, 2010
Race, Bleeding, and Outcomes in STEMI Patients Treated with Fibrinolytic Therapy
Rajendra H Mehta, Amanda Stebbins, Renato D Lopes, et al.
Vascular Medicine (London, England)
|
April 25, 2007
ACCF/SCAI/SVMB/SIR/ASITN 2007 Clinical Expert Consensus Document on carotid stenting
Eric R Bates, Joseph D Babb, Donald E Casey, et al.
Lancet (London, England)
|
September 4, 2009
Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials
Michelle L O'Donoghue, Eugene Braunwald, Elliott M Antman, et al.
JACC. Case Reports
|
February 13, 2023
2022 Year in Review: Countdown of the Best Manuscripts in 2022
Julia Grapsa, Mary Norine Walsh, Maurice Lionel Enriquez-Sarano, et al.
Journal of the American College of Cardiology
|
January 9, 2007
ACCF/SCAI/SVMB/SIR/ASITN 2007 clinical expert consensus document on carotid stenting: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting)
, , , et al.
Circulation
|
November 1, 2006
Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy
Duane S Pinto, Ajay J Kirtane, Brahmajee K Nallamothu, et al.
The American Journal of Cardiology
|
October 6, 2009
Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial
David J Maron, John A Spertus, G B John Mancini, et al.
Circulation. Cardiovascular Interventions
|
November 3, 2011
Angiographic disease progression and residual risk of cardiovascular events while on optimal medical therapy: observations from the COURAGE Trial
G B John Mancini, Pamela M Hartigan, Eric R Bates, et al.
American Heart Journal
|
September 11, 2013
Prognostic importance of coronary anatomy and left ventricular ejection fraction despite optimal therapy: assessment of residual risk in the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation Trial
G B John Mancini, Pamela M Hartigan, Eric R Bates, et al.
The Canadian Journal of Cardiology
|
August 28, 2004
ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction)
Elliott M Antman, Daniel T Anbe, Paul Wayne Armstrong, et al.
Page
of 24